Clorox (NYSE:CLX) Price Target Lowered to $95.00 at BNP Paribas Exane

Clorox (NYSE:CLX) had its price objective lowered by BNP Paribas Exane from $97.00 to $95.00 in a research report released on Monday,Benzinga reports. The firm currently has a neutral rating on the stock.

Several other equities analysts have also issued reports on CLX. Citigroup decreased their target price on Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $91.00 price target on shares of Clorox in a research report on Friday, May 1st. Evercore restated an “underperform” rating and set a $110.00 price objective on shares of Clorox in a report on Friday, May 1st. UBS Group boosted their price objective on shares of Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a report on Thursday, July 16th. Finally, TD Cowen increased their target price on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a report on Tuesday, March 31st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat.com, Clorox has an average rating of “Reduce” and an average price target of $103.33.

Clorox Price Performance

CLX opened at $96.33 on Monday. The company has a fifty day moving average price of $94.74 and a two-hundred day moving average price of $104.01. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. Clorox has a 52 week low of $84.70 and a 52 week high of $132.03. The firm has a market capitalization of $11.65 billion, a PE ratio of 15.64 and a beta of 0.54.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the company earned $1.45 EPS. The firm’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, analysts anticipate that Clorox will post 5.52 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.63% of the company’s stock.

Institutional Investors Weigh In On Clorox

Several large investors have recently made changes to their positions in the stock. Norges Bank bought a new position in shares of Clorox during the fourth quarter worth about $135,735,000. Invesco Ltd. lifted its stake in Clorox by 22.1% in the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after acquiring an additional 884,751 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Clorox by 6,907.9% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock worth $75,593,000 after acquiring an additional 739,005 shares during the last quarter. Worldquant Millennium Advisors LLC acquired a new position in Clorox during the 2nd quarter worth approximately $71,856,000. Finally, Two Sigma Investments LP grew its stake in shares of Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after acquiring an additional 439,797 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.